Verition Fund Management
QTTB icon

Verition Fund Management’s Q32 Bio QTTB Stock Holding History

Verition Fund Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-586
Closed -$17K – 2856
2022
Q3 		$17K Hold
586
– – ﹤0.01% 2812
2022
Q2 		$21K Buy
+586
New +$20K ﹤0.01% 2214
2020
Q4 		– Sell
-4,112
Closed -$792K – 1441
2020
Q3 		$792K Sell
4,112
-954
-19% -$214K 0.02% 431
2020
Q2 		$1.39M Buy
+5,066
New +$1.35M 0.05% 314

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Verition Fund Management's QTTB Position: Q4 2022 in Review

Verition Fund Management sold out of Q32 Bio (QTTB) in Q4 2022, closing a stake of 586 shares — an estimated $17K sold.

Verition Fund Management first reported a position in QTTB in Q2 2020 and held it in 4 quarters. The position peaked at $1.39M in Q2 2020. 79 funds tracked by Wall St. Rank hold QTTB as of Q4 2022.

  • Verition Fund Management reported no remaining Q32 Bio position as of Q4 2022 after selling out during the quarter.
  • Verition Fund Management sold 586 Q32 Bio shares in Q4 2022, an estimated $17K.
  • Verition Fund Management first reported a position in Q32 Bio in Q2 2020 and held it in 4 quarters.
  • Verition Fund Management's Q32 Bio position peaked at $1.39M in Q2 2020.
  • 79 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.